Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Renal Cell Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05220267
What this trial is testing

Anlotinib Plus Sintilimab as First-line Treatment for Advanced Non Clear Cell Renal Cell Carcinoma

Who this might be right for
Non Clear Cell Renal Carcinoma
Sun Yat-sen University 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07159191
What this trial is testing

Envafolimab Combined With Axitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Advanced Renal Cell Carcinoma (aRCC)
Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)Study completedNCT04758507
What this trial is testing

Fecal Microbiota Transplantation to Improve Efficacy of Immune Checkpoint Inhibitors in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Early research (Phase 1)Ended earlyNCT04272034
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+15 more
Incyte Corporation 105
Testing effectiveness (Phase 2)Study completedNCT00003102
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Cancer
Ludwig Institute for Cancer Research 15
Early research (Phase 1)Study completedNCT03849469
What this trial is testing

XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Who this might be right for
MelanomaCervical CarcinomaPancreatic Carcinoma+20 more
Xencor, Inc. 78
Testing effectiveness (Phase 2)Ended earlyNCT03024437
What this trial is testing

Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Metastatic CancerRenal Cancer
Roberto Pili 31
Testing effectiveness (Phase 2)Looking for participantsNCT06699602
What this trial is testing

Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Memorial Sloan Kettering Cancer Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT04198766
What this trial is testing

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Who this might be right for
Solid TumorNon-Small Cell Lung CancerHead and Neck Cancer+5 more
Inhibrx Biosciences, Inc 340
Testing effectiveness (Phase 2)Study completedNCT02460224
What this trial is testing

Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.

Who this might be right for
Advanced Solid Tumors
Novartis Pharmaceuticals 490
Testing effectiveness (Phase 2)Study completedNCT01164228
What this trial is testing

Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery

Who this might be right for
Kidney Cancer
ECOG-ACRIN Cancer Research Group 87
Testing effectiveness (Phase 2)UnknownNCT05262413
What this trial is testing

QL1706 Plus Lenvatinib in Subjects With Advanced Renal Cell Carcinoma(RCC)

Who this might be right for
Advanced Renal Cell Carcinoma
Qilu Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT03075423
What this trial is testing

Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCC

Who this might be right for
Metastatic Renal Cell Carcinoma
Goethe University 316
Testing effectiveness (Phase 2)Ended earlyNCT01545817
What this trial is testing

Everolimus Post Pazopanib Treatment in Metastatic or Advanced Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Novartis Pharmaceuticals 74
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07277972
What this trial is testing

Iparomlimab and Tuvonralimab Injection in Combination With Lenvatinib or Axitinib for the Treatment of Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma That Has Failed First-Line Systemic Therapy

Who this might be right for
RCC, Renal Cell Cancer
Tianjin Medical University Cancer Institute and Hospital 36
Not applicableActive Not RecruitingNCT06116253
What this trial is testing

Advanced Diffusion Imaging in Renal Cancer Patients

Who this might be right for
Renal Cancer
NYU Langone Health 39
Testing effectiveness (Phase 2)Study completedNCT01688973
What this trial is testing

Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery

Who this might be right for
Recurrent Renal Cell CarcinomaStage III Renal Cell CancerStage IV Renal Cell Cancer+2 more
National Cancer Institute (NCI) 55
Large-scale testing (Phase 3)Active Not RecruitingNCT04523272
What this trial is testing

TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal Cancer

Who this might be right for
Advanced Renal Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 528
Testing effectiveness (Phase 2)Study completedNCT00019539
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Stage IV Renal Cell CancerRecurrent Renal Cell Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT06730672
What this trial is testing

An Exploratory Study on the Failure of Immunotherapy With Voronib Combined With Everolimus

Who this might be right for
Renal Cell Carcinoma Stage I
Sun Yat-sen University 80
Next Page